Group- Versus Individual-Mindfulness-Based Cognitive Therapy: a Randomized Trial (G/I-MBCT)

University Medical Center Groningen (UMCG)

Status: Completed

Conditions: Depressive Symptoms

Treatments: Behavioral: Group-Mindfulness-Based Cognitive Therapy; Behavioral: Individual-Mindfulness-Based Cognitive Therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT02314390

FVHH

Details and patient eligibility

About

The purpose of this study is to determine whether both group and individual mindfulness-based cognitive therapy (MBCT) are effective in reducing depressive symptoms in patients with a chronic somatic disease.

Full description

Depression is a common co-morbidity in patients with a chronic somatic disease which has a negative impact on patients' physical and mental health. In recent years, Mindfulness-Based Cognitive Therapy (MBCT) has gained interest and popularity as a treatment not only for preventing recurrence of depression, but also to treat current symptoms. Usually, the training is delivered in group format, thus little is known about the feasibility and effectiveness of MBCT as an individual training.

This pilot study aims to compare the effectiveness and feasibility of group and individual MBCT in reducing depressive symptoms in patients with a chronic somatic disease.

Enrollment: 56 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Chronic somatic disease
• Age ≥ 18 and ≤ 70
• Depressive symptoms as assessed by BDI-II score ≥ 14 (cut-off score indicating the presence of at least mild symptoms of depression)

Exclusion criteria

• Not being able to read and write Dutch
• Severe (psychiatric) co-morbidity
• Acute suicidal ideations or behavior
• Receiving an alternative psychological treatment during or less than two months prior to starting the participation in the study

Using an antidepressant drug during participation in the present study is allowed, on condition that a patient has been on stable medication regimen for at least two months prior to inclusion in the study, and that no new treatment with an antidepressant is initiated during the course of the study

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

56 participants in 2 patient groups

G-MBCT

Experimental group

Description:

Group-Mindfulness-Based Cognitive Therapy

Treatment:

Behavioral: Group-Mindfulness-Based Cognitive Therapy

I-MBCT

Experimental group

Description:

Individual-Mindfulness-Based Cognitive Therapy

Treatment:

Behavioral: Individual-Mindfulness-Based Cognitive Therapy